Marco Thomann is a Principal Scientist specializing in Gene Therapy Development, with extensive experience at Roche, where they held various leadership roles from 2002 to 2022. They contributed to the analytical characterization of therapeutic antibodies and proteins, supporting vital stages in drug development such as CQA assessment and IND/BLA preparation. Marco holds a Dipl.-Ing. (FH) in Biotechnology/Bioinformatics, gained from 1999 to 2003.
This person is not in the org chart
This person is not in any teams
This person is not in any offices